Switch to:
Synageva BioPharma Corp (NAS:GEVA)
Current Ratio
25.93 (As of Mar. 2015)

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Synageva BioPharma Corp's current ratio for the quarter that ended in Mar. 2015 was 25.93.

Synageva BioPharma Corp has a current ratio of 25.93. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

Definition

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Synageva BioPharma Corp's Current Ratio for the fiscal year that ended in Dec. 2014 is calculated as

 Current Ratio (A: Dec. 2014 ) = Total Current Assets (A: Dec. 2014 ) / Total Current Liabilities (A: Dec. 2014 ) = 457.832 / 25.243 = 18.14

Synageva BioPharma Corp's Current Ratio for the quarter that ended in Mar. 2015 is calculated as

 Current Ratio (Q: Mar. 2015 ) = Total Current Assets (Q: Mar. 2015 ) / Total Current Liabilities (Q: Mar. 2015 ) = 722.278 / 27.852 = 25.93

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.

Related Terms

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 current ratio 6.04 7.01 12.55 9.06 8.51 10.12 7.83 17.21 29.94 18.14

Synageva BioPharma Corp Quarterly Data

 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 current ratio 17.21 30.03 23.53 32.78 29.94 34.07 20.01 21.65 18.14 25.93
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)